The dose may increase monthly, giving the gastrointestinal tract time to adjust
10.1007/s40263-021-00827-8 73 MaM
In the UK, licensed weight loss medications, including orlistat and GLP-1 receptor agonists such as semaglutide (Wegovy), work through distinct mechanisms and are prescribed under specific NICE eligibility criteria, and June 2026 brought the first oral GLP-1 for weight loss, the Wegovy pill, a once-daily tablet
Practical, sustainable eating guidance that complements your medication not a crash diet
However, the evidence is still evolving related to how these medications may impact complications related to obesity such as heart disease and diabetes. The Pharmaceutical Strategies Group (PSG), a pharmaceutical management consulting company, surveyed 180 benefits executives representing health plans, employers and unions and found that these drugs are a major concern